American Bio Medica Corp
OTC:ABMC

Watchlist Manager
American Bio Medica Corp Logo
American Bio Medica Corp
OTC:ABMC
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $48.1

American Bio Medica Corp
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

American Bio Medica Corp
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
American Bio Medica Corp
OTC:ABMC
Total Current Liabilities
$1.1m
CAGR 3-Years
-33%
CAGR 5-Years
-9%
CAGR 10-Years
-11%
Boston Scientific Corp
NYSE:BSX
Total Current Liabilities
$5.4B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%
Edwards Lifesciences Corp
NYSE:EW
Total Current Liabilities
$1.8B
CAGR 3-Years
21%
CAGR 5-Years
15%
CAGR 10-Years
14%
Stryker Corp
NYSE:SYK
Total Current Liabilities
$7.8B
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Total Current Liabilities
$16.5B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Liabilities
$2B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
15%
No Stocks Found

American Bio Medica Corp
Glance View

Market Cap
48.1 USD
Industry
Health Care

American Bio Medica Corp. is a biotechnology company. The company is headquartered in Kinderhook, New York. The firm's DOA POCT products offer employers, law enforcement, government, healthcare and education professionals to identify illicit drug use. The firm also provides strip manufacturing and assembly and packaging services for a diagnostic test to an unaffiliated third party that sells this product outside the United States and it manufactures a diagnostic product that is sold under a private label by an unaffiliated third party. Its range of products include Products for the Detection of Drugs in Urine, Rapid Drug Screen, RDS InCup, Rapid TOX, Rapid TOX Cup II, Private Label Products, Products for the Detection of Drugs in Oral Fluid, Products for the Detection of Drugs in Oral Fluid, OralStat and other products.

ABMC Intrinsic Value
Not Available

See Also

What is American Bio Medica Corp's Total Current Liabilities?
Total Current Liabilities
1.1m USD

Based on the financial report for Mar 31, 2023, American Bio Medica Corp's Total Current Liabilities amounts to 1.1m USD.

What is American Bio Medica Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-11%

Over the last year, the Total Current Liabilities growth was -61%. The average annual Total Current Liabilities growth rates for American Bio Medica Corp have been -33% over the past three years , -9% over the past five years , and -11% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett